Suppr超能文献

3例尿素循环缺陷患者接受亲属活体供肝移植治疗的报告。

Report of 3 Patients With Urea Cycle Defects Treated With Related Living-Donor Liver Transplant.

作者信息

Özçay Figen, Barış Zeren, Moray Gökhan, Haberal Nihan, Torgay Adnan, Haberal Mehmet

机构信息

From the Department of Pediatric Gastroenterology, Baskent University Faculty of Medicine, Ankara, Turkey.

出版信息

Exp Clin Transplant. 2015 Nov;13 Suppl 3:126-30. doi: 10.6002/ect.tdtd2015.P69.

Abstract

Urea cycle defects are a group of metabolic disorders caused by enzymatic disruption of the urea cycle pathway, transforming nitrogen to urea for excretion from the body. Severe cases present in early infancy with life-threatening metabolic decompensation, and these episodes of hyperammonemia can be fatal or result in permanent neurologic damage. Despite the progress in pharmacologic treatment, long-term survival is poor especially for severe cases. Liver transplant is an alternative treatment option, providing sufficient enzymatic activity and decreasing the risk of metabolic decompensation. Three patients with urea cycle defects received related living-donor liver transplants at our hospital. Patients presented with late-onset ornithine transcarbamylase deficiency, argininosuccinate lyase deficiency, and citrullinemia. Maximum pretransplant ammonia levels were between 232 and 400 μmol/L (normal range is 18-72 μmol/L), and maximum posttransplant values were 52 to 94 μmol/L. All patients stopped medical treatment and dietary protein restriction for urea cycle defects after transplant. The patient with late-onset ornithine transcarbamylase deficiency already had motor deficits related to recurrent hyperammonemia attacks pretransplant. A major improvement could not be achieved, and he is wheelchair dependent at the age of 6 years. The other 2 patients had normal motor and mental skills before transplant, which have continued 12 and 14 months after transplant. Hepatic artery thrombosis in the patient with the ornithine transcarbamylase deficiency, intraabdominal infection in the patient with argininosuccinate lyase deficiency, and posterior reversible encephalopathy syndrome in the patient with citrullinemia were early postoperative complications. Histopathologic changes in livers explanted from patients with ornithine transcarbamylase deficiency and citrullinemia were nonspecific. The argininosuccinate lyase-deficient patient had portoportal fibrosis and cirrhotic nodule formation. In conclusion, liver transplant was a lifesaving procedure for our patients. Proper timing for transplant is important because high ammonia levels may result in permanent neurologic damage; however, transplant at younger ages also may increase morbidity.

摘要

尿素循环缺陷是一组由尿素循环途径的酶促破坏引起的代谢紊乱,该途径将氮转化为尿素以便从体内排出。严重病例在婴儿早期出现危及生命的代谢失代偿,这些高氨血症发作可能是致命的,或导致永久性神经损伤。尽管药物治疗取得了进展,但长期生存率很低,尤其是严重病例。肝移植是一种替代治疗选择,可提供足够的酶活性并降低代谢失代偿的风险。我院有3例尿素循环缺陷患者接受了亲属活体供肝移植。患者分别表现为迟发性鸟氨酸转氨甲酰酶缺乏症、精氨琥珀酸裂解酶缺乏症和瓜氨酸血症。移植前最高氨水平在232至400μmol/L之间(正常范围为18 - 72μmol/L),移植后最高值为52至94μmol/L。所有患者移植后停止了针对尿素循环缺陷的药物治疗和饮食蛋白质限制。迟发性鸟氨酸转氨甲酰酶缺乏症患者在移植前已经因反复高氨血症发作而出现运动功能障碍。未能取得重大改善,他在6岁时依赖轮椅。另外2例患者在移植前运动和智力技能正常,移植后12个月和14个月仍保持正常。鸟氨酸转氨甲酰酶缺乏症患者发生肝动脉血栓形成,精氨琥珀酸裂解酶缺乏症患者发生腹腔内感染,瓜氨酸血症患者发生后部可逆性脑病综合征,均为术后早期并发症。从鸟氨酸转氨甲酰酶缺乏症和瓜氨酸血症患者切除的肝脏的组织病理学变化是非特异性的。精氨琥珀酸裂解酶缺乏症患者有门静脉纤维化和肝硬化结节形成。总之,肝移植对我们的患者来说是一种挽救生命的手术。合适的移植时机很重要,因为高氨水平可能导致永久性神经损伤;然而,较年轻年龄移植也可能增加发病率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验